Structure of the oncoprotein gankyrin in complex with S6 ATPase of the 26S proteasome

被引:59
作者
Nakamura, Yoshihiro
Nakano, Kazumi
Umehara, Takashi
Kimura, Mayumi
Hayashizaki, Yoshihide
Tanaka, Akiko
Horikoshi, Masami
Padmanabhan, Balasundaram
Yokoyama, Shigeyuki
机构
[1] RIKEN, Genom Sci Ctr, Yokohama, Kanagawa 2300045, Japan
[2] Univ Tokyo, Lab Dev Biol, Inst Mol Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan
[3] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130032, Japan
关键词
D O I
10.1016/j.str.2006.11.015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Gankyrin is an oncoprotein commonly overexpressed in most hepatocellular carcinomas. Gankyrin interacts with S6 ATPase of the 19S regulatory particle of the 26S proteasome and enhances the degradation of the tumor suppressors pRb and p53. Here, we report the structure of gankyrin in complex with the C-terminal domain of S6 ATPase. Almost all of the seven ankyrin repeats of gankyrin interact, through its concave region, with the C-terminal domain of S6 ATPase. The intermolecular interactions occur through the complementary charged residues between gankyrin and S6 ATPase. Biochemical studies based on the structure of the complex revealed that gankyrin interacts with pRb in both the presence and absence of S6 ATPase; however, the E182 residue in gankyrin is essential for the pRb interaction. These results provide a structural basis for the involvement of gankyrin in the pRb degradation pathway, through its association with S6 ATPase of the 26S proteasome.
引用
收藏
页码:179 / 189
页数:11
相关论文
共 45 条
[1]   A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans [J].
Bond, GL ;
Hu, WW ;
Bond, EE ;
Robins, H ;
Lutzker, SG ;
Arva, NC ;
Bargonetti, J ;
Bartel, F ;
Taubert, H ;
Wuerl, P ;
Onel, K ;
Yip, L ;
Hwang, SJ ;
Strong, LC ;
Lozano, G ;
Levine, AJ .
CELL, 2004, 119 (05) :591-602
[2]   Crystallography & NMR system:: A new software suite for macromolecular structure determination [J].
Brunger, AT ;
Adams, PD ;
Clore, GM ;
DeLano, WL ;
Gros, P ;
Grosse-Kunstleve, RW ;
Jiang, JS ;
Kuszewski, J ;
Nilges, M ;
Pannu, NS ;
Read, RJ ;
Rice, LM ;
Simonson, T ;
Warren, GL .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 :905-921
[3]   HEC binds to the seventh regulatory subunit of the 26 S proteasome and modulates the proteolysis of mitotic cyclins [J].
Chen, Y ;
Sharp, ZD ;
Lee, WH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (38) :24081-24087
[4]  
Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D B, V50, P760
[5]   Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation [J].
ConnellCrowley, L ;
Harper, JW ;
Goodrich, DW .
MOLECULAR BIOLOGY OF THE CELL, 1997, 8 (02) :287-301
[6]   Gankyrin is an ankyrin-repeat oncoprotein that interacts with CDK4 kinase and the S6 ATPase of the 26 S proteasome [J].
Dawson, S ;
Apcher, S ;
Mee, M ;
Higashitsuji, H ;
Baker, R ;
Uhle, S ;
Dubiel, W ;
Fujita, J ;
Mayer, RJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (13) :10893-10902
[7]   Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins [J].
Dick, FA ;
Sailhamer, E ;
Dyson, NJ .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (10) :3715-3727
[8]   ESPript:: analysis of multiple sequence alignments in PostScript [J].
Gouet, P ;
Courcelle, E ;
Stuart, DI ;
Métoz, F .
BIOINFORMATICS, 1999, 15 (04) :305-308
[9]   Structure of 20S proteasome from yeast at 2.4 angstrom resolution [J].
Groll, M ;
Ditzel, L ;
Lowe, J ;
Stock, D ;
Bochtler, M ;
Bartunik, HD ;
Huber, R .
NATURE, 1997, 386 (6624) :463-471
[10]   Polyubiquitination of p53 by a ubiquitin ligase activity of p300 [J].
Grossman, SR ;
Deato, ME ;
Brignone, C ;
Chan, HM ;
Kung, AL ;
Tagami, H ;
Nakatani, Y ;
Livingston, DM .
SCIENCE, 2003, 300 (5617) :342-344